Alternatives
Alternatives to Kenalog-10 50 mg/5 mL injectable suspension
1 other presentations of Triamcinolone acetonide 50 mg/5 mL injectable suspension
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Triamcinolone acetonide), strength (50 mg/5 mL) and dosage form (injectable suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Kenalog-10 50 mg/5 mL injectable suspensionThis pageIntra-articular, intralesional | ER Squibb & Sons | US FDA | 1 vial of 5 mL, 1 vial of 5 mL | Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), protect from temperatures below 20°C (68°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). Once in use: Chemical and physical in-use stability has been demonstrated for 28 days below 25°C (77°F). | On request | — | Available on request |
| Triamcinolone acetonide 50 mg/5 mL injectable suspensionIntra-articular, intralesional | — | US FDA | 1 vial of 5 mL | Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), protect from temperatures below 20°C (68°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). Once in use: Chemical and physical in-use stability has been demonstrated for 28 days at 20°C to 25°C (68°F to 77°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Kenalog-10 50 mg/5 mL injectable suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.